Bristol Myers Earnings Top Views; BMY Stock Just Below Buy Point

Early Wednesday, Bristol Myers Squibb (BMY) reported adjusted income of $1.93 per share on $11.7 billion in second-quarter sales. In response, BMY stock fell a fraction.


On average, BMY stock analysts polled by FactSet expected the pharmaceutical giant to earn $1.89 a share and report $11.27 billion in sales.

At this time last year, Bristol Myers earned $1.63 per share and the company reported $10.13 billion in sales.

For the year, Bristol Myers reaffirmed its adjusted EPS target of $7.35-$7.55. Analysts projected $7.45 earnings per share and $46.06 billion in sales.

In premarket trading on the stock market today, BMY stock dipped 0.4% to 67.20. Shares are trying to retake a buy point at 68.06 out of a flat base, according to

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Is Novavax Stock A Buy Or Sell As It Trails Covid Vaccine Leaders Pfizer, Moderna?

Boston Scientific Breaks Out After Sidestepping ‘Fears Of A Summer Slowdown’

Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists

Find Today’s Best Growth Stocks To Watch With IBD 50

IBD’s Leaderboard Is Turning 10! Help Us Celebrate

Most Related Links :
editorpen Governmental News Finance News

Source link

Back to top button